Pfizer Stock News

The US Food and Drug Administration (FDA) may take 55 years to release all the documents it used to declare Pfizer''s Covid-19 vaccine safe, a group of doctors and professors claim. The FDA approved Pfizer/BioNTech''s Covid-19 vaccine for people aged 16 and over in August, and, last month, extended its emergency-use authorization to children as young as five. This week, FDA regulators are expected

The delays come on the heels of reports, confirmed by Global News, that Health Canada on Friday will give the green light to Pfizer''s COVID-19 vaccine for kids aged five-11.

The US Food and Drug Administration (FDA) may take 55 years to release all the documents it used to declare Pfizers Covid-19 vaccine safe, a group of doctors and professors claim. Read Full Article at RT.com

DUBLIN, Nov. 18, 2021 /PRNewswire/ -- The "Global Auto Injector Market Outlook 2030" report has been added to ResearchAndMarkets.com''s offering. The market is estimated to garner a revenue of close to USD 11350 Million by the end of 2030, up from a revenue of about USD 3120 Million in the

The German vaccination committee STIKO advises all vaccinated adults to give an extra shot with the corona vaccines from Pfizer/BioNTech or Moderna. The so-called booster shot is currently only available for the oldest residents of Germany and other risk groups. According to the committee, the booster should ensure that vaccinated persons remain well protected […] The post German Vaccination Commission Recommends Boosters for People Over 18 appeared first on Dawn News .

Pfizer Inc (NYSE: PFE ) has made a $15 million equity investment in Cardiff Oncology Inc (NASDAQ: CRDF ) as part of the Pfizer Breakthrough Growth Initiative. Pfizer purchased 2.4 million shares of Cardiff Oncology''s shares at $6.22 Full story available on Benzinga.com

DBMR has added a new report titled Anti-Infective Drugs Market with data Tables for historical and forecast years represented with Chats & Graphs spread through Pages with easy to understand detailed analysis. This research report is generated by thoroughly understanding

U.S. government officials have reached an agreement with Pfizer that secures 10 million courses of the drugmakers COVID-19 pill. The government is paying $5.3 billion, or $529 a course for the pill. The price is due to the high committed volume of treatment courses being purchased through 2022, with similar agreements reached with several other []

Typically, metastatic cancer requires systemic therapy, or medications given by mouth or injected into the bloodstream to reach cancer cells throughout the body, such as chemotherapy or hormone therapy. The Global Metastatic Cancer Treatment Market Report presents a comprehensive overview

Pfizer asked the FDA on Tuesday to authorize emergency use of the experimental pill, which has been shown to significantly cut the rate of hospitalizations and deaths among people with coronavirus infections

FDA Wants Until 2076 To Fully Release Pfizer Vaccine Data: Lawsuit Authored by attorney Aaron Siri via Injecting Freedom (emphasis ours), The FDA has asked a federal judge to make the public wait until the year 2076 to disclose all of the data and information it relied upon to license Pfizers COVID-19 vaccine . That is not a typo. It wants 55 years to produce this information to the public. As explained in a prior article , the FDA repeatedly promised full transparency with regard to Covid-19 vaccines, including reaffirming the FDAs commitment to transparency when licensing Pfizers COVID-19 vaccine. With that promise in mind, in August and immediately following approval of the vaccine, more than 30 academics, professors, and scientists from this countrys most prestigious universities requested the data and information submitted to the FDA by Pfizer to license its COVID-19 vaccine . The FDAs response? It produced nothing . So, in September, my firm filed a lawsuit against the FDA on behalf of this group to demand this information.

On October 29, the Food and Drug Administration granted emergency use authorization of the Pfizer COVID-19 vaccine in children aged 5 to 11. Four days later, the Centers for Disease Control and Prevention recommended the vaccine for this age group, expanding its eligibility to 28 million kids. And while more than one million children have […]

All Global Research articles can be read in 51 languages by activating the “Translate Website” drop down menu on the top banner of our home page (Desktop version). To receive Global Research’s Daily Newsletter (selected articles), click here . Visit … The post Vaccine Injury Attorney Suing the FDA: FDA Asks Federal Judge to Grant it Until the Year 2076 to Fully Release Pfizer’s COVID-19 Vaccine Data appeared first on Global Research .